Author:
Salem Mohamed L.,Al-Khami Amir A.,El-Nagaar Sabry A.,Zidan Abdel-Aziz A.,Al-Sharkawi Ismail M.,Marcela Díaz-Montero C.,Cole David J.
Reference38 articles.
1. Immunopotentiation with low-dose cyclophosphamide in the active specific immunotherapy of cancer;Bass;Cancer Immunol. Immunother.,1998
2. Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide;Brode;Crit. Rev. Immunol.,2008
3. Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice;Machiels;Cancer Res.,2001
4. Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model;Hermans;Cancer Res.,2003
5. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice;Proietti;J. Clin. Invest.,1998
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献